Hepion Pharmaceuticals, Inc. (HEPA) - Stock Prices, Stock Peers & Analysis

Home
HEPA

Company Name	Hepion Pharmaceuticals, Inc.
Symbol	HEPA
Currency	USD
Price	0.495
Market Cap Market Cap The market capitalization (market cap) of a stock represents the total market value of a company's outstanding shares of stock. It's a key metric used to gauge a company's size and investment risk, and it can be an important factor in investment decisions. Here's how it's calculated: Market Cap = Number of Outstanding Shares × Current Share Price	3,444,393
Dividend Yield Dividend Yield The dividend yield is a financial ratio that measures the amount of cash dividends distributed to common shareholders relative to the market value per share. The dividend yield is represented as a percentage and can be calculated by dividing the dollar value of dividends paid in a given year per share of stock held by the dollar value of one share of stock. Here's how it's calculated: Dividend Yield = Annual Dividends per Share / Price per Share	0%
52-week-range	0.461 - 3.69
Industry	Biotechnology
Sector	Healthcare
CEO	Dr. Robert T. Foster B.Sc., BSc (Pharm), Ph.D., Pharm.D.
Website	https://www.hepionpharma.com

An error occurred while fetching data.

About Hepion Pharmaceuticals, Inc.

Hepion Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of drug therapy treatment for chronic liver diseases in the United States. It is involved in developing Rencofilstat, a cyclophilin inhibitor that has completed Phase 2a clinical trials to target multiple pathologic pathways involved in the progression of liver disease;